
|Articles|March 19, 2021
Process Robustness and Product Quality for Late-Stage API Crystallization Using a Standardized Project Flow
Author(s)WuXi STA, a WuXi AppTec Company
Trending on Pharmaceutical Technology
1
The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma
2
The FDA Moves to Modernize Drug Manufacturing Registration
3
PharmTech Weekly Roundup–July 10, 2026
4
What the Ocrelizumab Deal Does for the Multiple Sclerosis Biosimilar Pipeline
5